Past Studies
The UW Virology Research Clinic has conducted natural history studies as well as clinical trials of investigational medications, vaccines, and other therapies over the decades. Here is a sample of our past research.
Genital Herpes Simplex Virus Types 2 (HSV-2)
- Genocea Phase 1: Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine
- Genocea Phase 2: Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine
- Genocea Phase 2 follow up: Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity
- Genocea Phase 2: Evaluating New Formulation of Therapeutic HSV-2 Vaccine
- Genocea Phase 2 follow up: Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection
- Vical Phase 1: Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults
- Vical Phase 2: Phase 2 Trial to Evaluate the Safety and Efficacy of HSV-2 Therapeutic DNA Vaccine (Placebo-Controlled)
- Sanofi Pasteur Phase 1: HSV529 Vaccine in HSV-2 Seropositive Adults
- Agenus Phase 1: Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
- AiCuris Phase 1: Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2
- AiCuris Phase 2: Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes
- Gilead Sciences: Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
Investigational H1N1 Influenza Vaccines
- With and without adjuvant in healthy adult and elderly populations (Sanofi)
- In health adult and elderly populations (CSL)
- In HIV+ population
Smallpox
Malaria